COVID-19 disease severity was found to be reduced by oral fluvoxamine combined with budesonide.

Published Date: 19 Apr 2023

Treatment with oral fluvoxamine plus budesonide for high-risk outpatients with COVID-19 lowers the likelihood of severe disease requiring advanced care, per a study published online April 18 in the Annals of Internal.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Common intracellular toxin could help fight leukemia

2.

CAR T-Cell Therapy Shows Promise in Mantle Cell Lymphoma

3.

Scholastic performance is a key concern for young cancer patients, study finds

4.

AACR: American Association for Cancer Research

5.

Lung Cancer Screening Rates in Eligible Adults Remain Low, Uneven


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot